Public Health Issues in Pharmacogenomics

Marius Geanta; Bianca Cucos; Angela Brand

doi:10.1007/978-3-031-45903-0_18

Public Health Issues in Pharmacogenomics

Marius Geanta^*, Bianca Cucos, Angela Brand

^*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic

Abstract

COVID-19 is the first pandemic in the post-genomic era, showcasing how advancements in fundamental research can be translated for real-time, global monitoring of viral variants, identifying the viral origin, understanding the host responses and differences in outcomes, as well as for drug repurposing and drug discovery. Genomic epidemiology and precision public health are some of the interdisciplinary fields which have come of age during this pandemic. Genomics will likely become an essential component of public health strategies for communicable and non-communicable diseases. Genomic medicine leads to disruption in terms of clinical management of the individual patient (precision medicine) or population health (precision public health).

Original language	English
Title of host publication	Pharmacogenomics in Clinical Practice
Editors	Dragan Primorac, Wolfgang Höppner, Lidija Bach-Rojecky
Publisher	Springer
Pages	325-346
Number of pages	22
Edition	1
ISBN (Electronic)	9783031459030
ISBN (Print)	9783031459023
DOIs	https://doi.org/10.1007/978-3-031-45903-0_18
Publication status	Published - 1 Jan 2024

Access to Document

10.1007/978-3-031-45903-0_18

Cite this

@inbook{9fad17ca27cd4e5f9facc05a9a4de7eb,

title = "Public Health Issues in Pharmacogenomics",

abstract = "COVID-19 is the first pandemic in the post-genomic era, showcasing how advancements in fundamental research can be translated for real-time, global monitoring of viral variants, identifying the viral origin, understanding the host responses and differences in outcomes, as well as for drug repurposing and drug discovery. Genomic epidemiology and precision public health are some of the interdisciplinary fields which have come of age during this pandemic. Genomics will likely become an essential component of public health strategies for communicable and non-communicable diseases. Genomic medicine leads to disruption in terms of clinical management of the individual patient (precision medicine) or population health (precision public health).",

author = "Marius Geanta and Bianca Cucos and Angela Brand",

note = "Publisher Copyright: {\textcopyright} The Author(s), under exclusive license to Springer Nature Switzerland AG 2023.",

year = "2024",

month = jan,

day = "1",

doi = "10.1007/978-3-031-45903-0_18",

language = "English",

isbn = "9783031459023",

pages = "325--346",

editor = "Dragan Primorac and Wolfgang H{\"o}ppner and Lidija Bach-Rojecky",

booktitle = "Pharmacogenomics in Clinical Practice",

publisher = "Springer",

address = "United States",

edition = "1",

}

TY - CHAP

T1 - Public Health Issues in Pharmacogenomics

AU - Geanta, Marius

AU - Cucos, Bianca

AU - Brand, Angela

PY - 2024/1/1

Y1 - 2024/1/1

N2 - COVID-19 is the first pandemic in the post-genomic era, showcasing how advancements in fundamental research can be translated for real-time, global monitoring of viral variants, identifying the viral origin, understanding the host responses and differences in outcomes, as well as for drug repurposing and drug discovery. Genomic epidemiology and precision public health are some of the interdisciplinary fields which have come of age during this pandemic. Genomics will likely become an essential component of public health strategies for communicable and non-communicable diseases. Genomic medicine leads to disruption in terms of clinical management of the individual patient (precision medicine) or population health (precision public health).

AB - COVID-19 is the first pandemic in the post-genomic era, showcasing how advancements in fundamental research can be translated for real-time, global monitoring of viral variants, identifying the viral origin, understanding the host responses and differences in outcomes, as well as for drug repurposing and drug discovery. Genomic epidemiology and precision public health are some of the interdisciplinary fields which have come of age during this pandemic. Genomics will likely become an essential component of public health strategies for communicable and non-communicable diseases. Genomic medicine leads to disruption in terms of clinical management of the individual patient (precision medicine) or population health (precision public health).

U2 - 10.1007/978-3-031-45903-0_18

DO - 10.1007/978-3-031-45903-0_18

M3 - Chapter

SN - 9783031459023

SP - 325

EP - 346

BT - Pharmacogenomics in Clinical Practice

A2 - Primorac, Dragan

A2 - Höppner, Wolfgang

A2 - Bach-Rojecky, Lidija

PB - Springer

ER -

Public Health Issues in Pharmacogenomics

Abstract

Access to Document

Fingerprint

Cite this